Search

Your search keyword '"Linn, S.C."' showing total 333 results

Search Constraints

Start Over You searched for: Author "Linn, S.C." Remove constraint Author: "Linn, S.C."
333 results on '"Linn, S.C."'

Search Results

1. Intensified alkylating chemotherapy for patients with oligometastatic breast cancer harboring homologous recombination deficiency: Primary outcomes from the randomized phase III OLIGO study

2. Prognostic value of histopathologic traits independent of stromal tumor-infiltrating lymphocyte levels in chemotherapy-naïve patients with triple-negative breast cancer

5. Quality assurance of radiation therapy after breast-conserving surgery among patients in the BOOG 2013-08 trial

6. 163MO Single-cell T cell dynamics induced by neoadjuvant nivolumab +/- ipilimumab in early triple negative breast cancer with tumor-infiltrating lymphocytes (BELLINI trial)

9. Stimulation of the ovaries in women with breast cancer undergoing fertility preservation: Alternative versus standard stimulation protocols; the study protocol of the STIM-trial

10. 94MO The prognostic and predictive effect of BMI in postmenopausal HR+ breast cancer patients receiving (extended) endocrine therapy: DATA trial analysis

18. Impact of lymphedema on health-related quality of life in early-stage breast cancer patients treated breast conserving therapy with or without sentinel lymph node biopsy: 2-year results from the randomized controlled trial BOOG2013–08

19. External validation and clinical utility assessment of PREDICT v2.2 prognostic model in young, node-negative, systemic treatment-naïve breast cancer patients

21. LBA13 Nivolumab and ipilimumab in early-stage triple negative breast cancer (TNBC) with tumor-infiltrating lymphocytes (TILs): First results from the BELLINI trial

23. 133O Extended adjuvant aromatase inhibition after sequential endocrine therapy: Final results of the phase III DATA trial

26. Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial

36. LBA18 POSEIDON randomized phase II trial: Tamoxifen (TAM) + taselisib or placebo (PLA) in patients (pts) with hormone receptor positive (HR+)/HER2- metastatic breast cancer (MBC)

37. 9P BRCA1 promoter methylation confers a more favorable prognosis to systemically untreated young triple-negative breast cancer patients than tumour BRCA1 mutation

38. Breast cancer outcome in relation to bone mineral density and bisphosphonate use

39. Assessment of structural chromosomal instability phenotypes as biomarkers of carboplatin response in triple negative breast cancer: the TNT trial

41. Measurement of the phase difference between short- and long-distance amplitudes in the B+ -> K+ mu(+) mu(-) decay

42. Cancer-immune interactions in ER-positive breast cancers

43. Efficacy of anastrozole after tamoxifen in early breast cancer patients with chemotherapy-induced ovarian function failure

44. Assessment and management of bone health in women with early breast cancer receiving endocrine treatment in the DATA study

45. 159 (PB-072) Poster - Impact of lymphedema on health-related quality of life in early-stage breast cancer patients treated breast conserving therapy with or without sentinel lymph node biopsy: 2-year results from the randomized controlled trial BOOG2013–08

46. 13 (PB-009) Poster Discussion - External validation and clinical utility assessment of PREDICT v2.2 prognostic model in young, node-negative, systemic treatment-naïve breast cancer patients

48. Assessment and management of bone health in women with early breast cancer receiving endocrine treatment in the DATA study

49. Assessment and management of bone health in women with early breast cancer receiving endocrine treatment in the DATA study

50. Efficacy of anastrozole after tamoxifen in early breast cancer patients with chemotherapy-induced ovarian function failure

Catalog

Books, media, physical & digital resources